Sanofi, through its philanthropic organisation Foundation S, is celebrating the 25th anniversary of The Gaucher Initiative, a ...

(AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that AB ...

Q3 2024 Earnings Call Transcript November 6, 2024 Amicus Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

The firm says both the company’s Pompe and Fabry disease franchises have “significant levers that could be used to generate a steady stream of revenue growth.” It is a buyer on the stock into 2025.

Amicus Therapeutics Inc (FOLD) reports a 37% revenue increase and raises full-year guidance, despite ongoing litigation challenges.

11.3. The Advisory Committee recommended that avalglucosidase alfa for the treatment of late onset Pompe disease be funded with a medium priority.

The Delhi High Court has directed the Union Government to establish the National Fund for Rare Diseases (NFRD). What are rare diseases? What are the government policies for rare diseases? Take a look.

Group 3 covers conditions like Gaucher Disease and Pompe Disease, where treatment is available but complicated by high costs ...

Cardiovascular disease is a group of conditions that affect your heart and blood vessels. It's sometimes also called heart disease. Conditions that affect your heart and blood vessels can include ...

He added that registries from specific companies can be useful resources, referencing Sanofi’s Rare Disease Registries which records information about rare conditions such as Gaucher disease, Fabry ...